Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000250131 | SCV000307344 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Invitae | RCV001068932 | SCV001234069 | uncertain significance | Nemaline myopathy 2 | 2019-06-24 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid with glutamine at codon 1125 of the NEB protein (p.Glu1125Gln). The glutamic acid residue is moderately conserved and there is a small physicochemical difference between glutamic acid and glutamine. This variant is present in population databases (rs757784515, ExAC 0.002%). This variant has not been reported in the literature in individuals with NEB-related conditions. ClinVar contains an entry for this variant (Variation ID: 257809). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |